Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type (2014-2025) 1.4.2 HSV-based Oncolytic Viruses 1.4.3 Adenoviruses-based Oncolytic Viruses 1.4.4 Vaccinia Virus-based Oncolytic Viruses 1.4.5 Vesicular Stomatitis Virus-based Oncolytic Viruses 1.4.6 Newcastle Disease Virus-based Oncolytic Viruses 1.5 Market by Application 1.5.1 Global Oncolytic Virus Therapy Market Share by Application (2014-2025) 1.5.2 Melanoma 1.5.3 Prostate Cancer 1.5.4 Breast Cancer 1.5.5 Ovarian Cancer  1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Oncolytic Virus Therapy Market Size 2.2 Oncolytic Virus Therapy Growth Trends by Regions 2.2.1 Oncolytic Virus Therapy Market Size by Regions (2014-2025) 2.2.2 Oncolytic Virus Therapy Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Oncolytic Virus Therapy Market Size by Manufacturers 3.1.1 Global Oncolytic Virus Therapy Revenue by Manufacturers (2014-2019) 3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI) 3.2 Oncolytic Virus Therapy Key Players Head office and Area Served 3.3 Key Players Oncolytic Virus Therapy Product/Solution/Service 3.4 Date of Enter into Oncolytic Virus Therapy Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Oncolytic Virus Therapy Market Size by Type (2014-2019) 4.2 Global Oncolytic Virus Therapy Market Size by Application (2014-2019) 5 United States 5.1 United States Oncolytic Virus Therapy Market Size (2014-2019) 5.2 Oncolytic Virus Therapy Key Players in United States 5.3 United States Oncolytic Virus Therapy Market Size by Type 5.4 United States Oncolytic Virus Therapy Market Size by Application 6 Europe 6.1 Europe Oncolytic Virus Therapy Market Size (2014-2019) 6.2 Oncolytic Virus Therapy Key Players in Europe 6.3 Europe Oncolytic Virus Therapy Market Size by Type 6.4 Europe Oncolytic Virus Therapy Market Size by Application 7 China 7.1 China Oncolytic Virus Therapy Market Size (2014-2019) 7.2 Oncolytic Virus Therapy Key Players in China 7.3 China Oncolytic Virus Therapy Market Size by Type 7.4 China Oncolytic Virus Therapy Market Size by Application 8 Japan 8.1 Japan Oncolytic Virus Therapy Market Size (2014-2019) 8.2 Oncolytic Virus Therapy Key Players in Japan 8.3 Japan Oncolytic Virus Therapy Market Size by Type 8.4 Japan Oncolytic Virus Therapy Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Oncolytic Virus Therapy Market Size (2014-2019) 9.2 Oncolytic Virus Therapy Key Players in Southeast Asia 9.3 Southeast Asia Oncolytic Virus Therapy Market Size by Type 9.4 Southeast Asia Oncolytic Virus Therapy Market Size by Application 10 India 10.1 India Oncolytic Virus Therapy Market Size (2014-2019) 10.2 Oncolytic Virus Therapy Key Players in India 10.3 India Oncolytic Virus Therapy Market Size by Type 10.4 India Oncolytic Virus Therapy Market Size by Application 11 Central & South America 11.1 Central & South America Oncolytic Virus Therapy Market Size (2014-2019) 11.2 Oncolytic Virus Therapy Key Players in Central & South America 11.3 Central & South America Oncolytic Virus Therapy Market Size by Type 11.4 Central & South America Oncolytic Virus Therapy Market Size by Application 12 International Players Profiles 12.1 Amgen 12.1.1 Amgen Company Details 12.1.2 Company Description and Business Overview 12.1.3 Oncolytic Virus Therapy Introduction 12.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.1.5 Amgen Recent Development 12.2 Oncolytics Biotech 12.2.1 Oncolytics Biotech Company Details 12.2.2 Company Description and Business Overview 12.2.3 Oncolytic Virus Therapy Introduction 12.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.2.5 Oncolytics Biotech Recent Development 12.3 Viralytics 12.3.1 Viralytics Company Details 12.3.2 Company Description and Business Overview 12.3.3 Oncolytic Virus Therapy Introduction 12.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.3.5 Viralytics Recent Development 12.4 Transgene SA 12.4.1 Transgene SA Company Details 12.4.2 Company Description and Business Overview 12.4.3 Oncolytic Virus Therapy Introduction 12.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.4.5 Transgene SA Recent Development 12.5 Oncolys BioPharma 12.5.1 Oncolys BioPharma Company Details 12.5.2 Company Description and Business Overview 12.5.3 Oncolytic Virus Therapy Introduction 12.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.5.5 Oncolys BioPharma Recent Development 12.6 Targovax 12.6.1 Targovax Company Details 12.6.2 Company Description and Business Overview 12.6.3 Oncolytic Virus Therapy Introduction 12.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.6.5 Targovax Recent Development 12.7 PsiOxus Therapeutics 12.7.1 PsiOxus Therapeutics Company Details 12.7.2 Company Description and Business Overview 12.7.3 Oncolytic Virus Therapy Introduction 12.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.7.5 PsiOxus Therapeutics Recent Development 12.8 SillaJen Biotherapeutics 12.8.1 SillaJen Biotherapeutics Company Details 12.8.2 Company Description and Business Overview 12.8.3 Oncolytic Virus Therapy Introduction 12.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.8.5 SillaJen Biotherapeutics Recent Development 12.9 Sorrento Therapeutics 12.9.1 Sorrento Therapeutics Company Details 12.9.2 Company Description and Business Overview 12.9.3 Oncolytic Virus Therapy Introduction 12.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.9.5 Sorrento Therapeutics Recent Development 12.10 Lokon Pharma 12.10.1 Lokon Pharma Company Details 12.10.2 Company Description and Business Overview 12.10.3 Oncolytic Virus Therapy Introduction 12.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2014-2019) 12.10.5 Lokon Pharma Recent Development 12.11 Genelux Corporation 12.12 Vyriad 12.13 TILT Biotherapeutics 12.14 Cold Genesys 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Oncolytic Virus Therapy Key Market Segments Table Key Players Oncolytic Virus Therapy Covered Table Global Oncolytic Virus Therapy Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Oncolytic Virus Therapy Market Size Market Share by Type 2014-2025 Figure HSV-based Oncolytic Viruses Figures Table Key Players of HSV-based Oncolytic Viruses Figure Adenoviruses-based Oncolytic Viruses Figures Table Key Players of Adenoviruses-based Oncolytic Viruses Figure Vaccinia Virus-based Oncolytic Viruses Figures Table Key Players of Vaccinia Virus-based Oncolytic Viruses Figure Vesicular Stomatitis Virus-based Oncolytic Viruses Figures Table Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses Figure Newcastle Disease Virus-based Oncolytic Viruses Figures Table Key Players of Newcastle Disease Virus-based Oncolytic Viruses Table Global Oncolytic Virus Therapy Market Size Growth by Application 2014-2025 (Million US$) Figure Melanoma Case Studies Figure Prostate Cancer Case Studies Figure Breast Cancer Case Studies Figure Ovarian Cancer  Case Studies Figure Others Case Studies Figure Oncolytic Virus Therapy Report Years Considered Table Global Oncolytic Virus Therapy Market Size 2014-2025 (Million US$) Figure Global Oncolytic Virus Therapy Market Size and Growth Rate 2014-2025 (Million US$) Table Global Oncolytic Virus Therapy Market Size by Regions 2014-2025 (Million US$) Table Global Oncolytic Virus Therapy Market Size by Regions 2014-2019 (Million US$) Table Global Oncolytic Virus Therapy Market Share by Regions 2014-2019 Figure Global Oncolytic Virus Therapy Market Share by Regions 2014-2019 Figure Global Oncolytic Virus Therapy Market Share by Regions 2019 Table Market Top Trends Table Global Oncolytic Virus Therapy Revenue by Manufacturers (2014-2019) (Million US$) Table Global Oncolytic Virus Therapy Market Share by Manufacturers (2014-2019) Figure Global Oncolytic Virus Therapy Market Share by Manufacturers in 2018 Table Global Oncolytic Virus Therapy Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Oncolytic Virus Therapy Product/Solution/Service Table Date of Enter into Oncolytic Virus Therapy Market Table Mergers & Acquisitions, Expansion Plans Table Global Oncolytic Virus Therapy Market Size by Type (2014-2019) (Million US$) Table Global Oncolytic Virus Therapy Market Size Share by Type (2014-2019) Figure Global Oncolytic Virus Therapy Market Size Market Share by Type (2014-2019) Table Global Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table Global Oncolytic Virus Therapy Market Size Share by Application (2014-2019) Figure Global Oncolytic Virus Therapy Market Size Market Share by Application (2014-2019) Figure Global Oncolytic Virus Therapy Revenue Market Share by Application in 2018 Figure United States Oncolytic Virus Therapy Market Size 2014-2019 (Million US$) Table United States Key Players Oncolytic Virus Therapy Revenue (2018-2019) (Million US$) Table United States Key Players Oncolytic Virus Therapy Market Share (2018-2019) Table United States Oncolytic Virus Therapy Market Size by Type (2014-2019) (Million US$) Table United States Oncolytic Virus Therapy Market Share by Type (2014-2019) Table United States Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table United States Oncolytic Virus Therapy Market Share by Application (2014-2019) Figure Europe Oncolytic Virus Therapy Market Size 2014-2019 (Million US$) Table Europe Key Players Oncolytic Virus Therapy Revenue (2018-2019) (Million US$) Table Europe Key Players Oncolytic Virus Therapy Market Share (2018-2019) Table Europe Oncolytic Virus Therapy Market Size by Type (2014-2019) (Million US$) Table Europe Oncolytic Virus Therapy Market Share by Type (2014-2019) Table Europe Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table Europe Oncolytic Virus Therapy Market Share by Application (2014-2019) Figure China Oncolytic Virus Therapy Market Size 2014-2019 (Million US$) Table China Key Players Oncolytic Virus Therapy Revenue (2018-2019) (Million US$) Table China Key Players Oncolytic Virus Therapy Market Share (2018-2019) Table China Oncolytic Virus Therapy Market Size by Type (2014-20189) (Million US$) Table China Oncolytic Virus Therapy Market Share by Type (2014-2019) Table China Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table China Oncolytic Virus Therapy Market Share by Application (2014-2019) Figure Japan Oncolytic Virus Therapy Market Size 2014-2019 (Million US$) Table Japan Key Players Oncolytic Virus Therapy Revenue (2018-2019) (Million US$) Table Japan Key Players Oncolytic Virus Therapy Market Share (2018-2019) Table Japan Oncolytic Virus Therapy Market Size by Type (2014-2019) (Million US$) Table Japan Oncolytic Virus Therapy Market Share by Type (2014-2019) Table Japan Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table Japan Oncolytic Virus Therapy Market Share by Application (2014-2019) Figure Southeast Asia Oncolytic Virus Therapy Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Oncolytic Virus Therapy Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Oncolytic Virus Therapy Market Share (2018-2019) Table Southeast Asia Oncolytic Virus Therapy Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Oncolytic Virus Therapy Market Share by Type (2014-2019) Table Southeast Asia Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Oncolytic Virus Therapy Market Share by Application (2014-2019) Figure India Oncolytic Virus Therapy Market Size 2014-2019 (Million US$) Table India Key Players Oncolytic Virus Therapy Revenue (2018-2019) (Million US$) Table India Key Players Oncolytic Virus Therapy Market Share (2018-2019) Table India Oncolytic Virus Therapy Market Size by Type (2014-2019) (Million US$) Table India Oncolytic Virus Therapy Market Share by Type (2014-2019) Table India Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table India Oncolytic Virus Therapy Market Share by Application (2014-2019) Figure Central & South America Oncolytic Virus Therapy Market Size 2014-2019 (Million US$) Table Central & South America Key Players Oncolytic Virus Therapy Revenue (2018-2019) (Million US$) Table Central & South America Key Players Oncolytic Virus Therapy Market Share (2018-2019) Table Central & South America Oncolytic Virus Therapy Market Size by Type (2014-2019) (Million US$) Table Central & South America Oncolytic Virus Therapy Market Share by Type (2014-2019) Table Central & South America Oncolytic Virus Therapy Market Size by Application (2014-2019) (Million US$) Table Central & South America Oncolytic Virus Therapy Market Share by Application (2014-2019) Table Amgen Company Details Table Amgen Revenue in Oncolytic Virus Therapy Business (2014-2019) (Million US$) Figure Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Amgen Recent Development Table Oncolytics Biotech Company Details Table Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Oncolytics Biotech Recent Development Table Viralytics Company Details Table Viralytics Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Viralytics Recent Development Table Transgene SA Company Details Table Transgene SA Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Transgene SA Recent Development Table Oncolys BioPharma Company Details Table Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Oncolys BioPharma Recent Development Table Targovax Company Details Table Targovax Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Targovax Recent Development Table PsiOxus Therapeutics Company Details Table PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table PsiOxus Therapeutics Recent Development Table SillaJen Biotherapeutics Company Details Table SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table SillaJen Biotherapeutics Recent Development Table Sorrento Therapeutics Company Details Table Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Sorrento Therapeutics Recent Development Table Lokon Pharma Company Details Table Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2014-2019)(Million US$) Figure Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2014-2019) Table Lokon Pharma Recent Development Table Genelux Corporation Company Details Table Vyriad Company Details Table TILT Biotherapeutics Company Details Table Cold Genesys Company Details Table Global Oncolytic Virus Therapy Market Size by Regions (Million US$) 2019-2025 Figure Global Oncolytic Virus Therapy Market Size Share by Regions (2019-2025) Figure Global Oncolytic Virus Therapy Market Size Share by Regions in 2025 Figure United States Oncolytic Virus Therapy Market Size Forecast (2019-2025)(Million USD) Figure Europe Oncolytic Virus Therapy Market Size Forecast (2019-2025)(Million USD) Figure China Oncolytic Virus Therapy Market Size Forecast (2019-2025)(Million USD) Figure Japan Oncolytic Virus Therapy Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Oncolytic Virus Therapy Market Size Forecast (2019-2025)(Million USD) Figure India Oncolytic Virus Therapy Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Oncolytic Virus Therapy Market Size Forecast (2019-2025)(Million USD) Table Global Oncolytic Virus Therapy Market Size by Product (2019-2025) (Million US$) Figure Global Oncolytic Virus Therapy Market Size by Product (2019-2025) Figure Global Oncolytic Virus Therapy Market Size by Product in 2025 Table Global Oncolytic Virus Therapy Market Size by Application (2019-2025) (Million US$) Figure Global Oncolytic Virus Therapy Market Size by Application (2019-2025) Figure Global Oncolytic Virus Therapy Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Amgen Oncolytics Biotech Viralytics Transgene SA Oncolys BioPharma Targovax PsiOxus Therapeutics SillaJen Biotherapeutics Sorrento Therapeutics Lokon Pharma Genelux Corporation Vyriad TILT Biotherapeutics Cold Genesys